Katrien Bomhals

Katrien Bomhals

Auto-generated profile, based on publicly available information

Katrien Bomhals

University Hospital Würzburg, Institute of Experimental Biomedicine

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 October 2023 in Philosophical Transactions of the Royal Society B: Biological Sciences
Verified
Journal Article
Closed access
SBStijn Van Bruggen
Stijn Van Bruggen
SKSirima Kraisin
Sirima Kraisin
JWJore Van Wauwe
Jore Van Wauwe
KBKatrien Bomhals
Katrien Bomhals
MSMathias Stroobants
Mathias Stroobants
KMKimberly Martinod
Kimberly Martinod
Mice fully deficient in peptidylarginine deiminase 4 (PAD4) enzyme have preserved cardiac function and reduced collagen deposition during ageing. The cellular source of PAD4 is hypothesized to be neutrophils, likely due to PAD4's involvement in neutrophil extracellular trap release. We investigated haematopoietic PAD4 impact on myocardial remodelling and systemic inflammation in cardiac ageing by generating mice with Padi4 deletion in circulating neutrophils under the MRP8 promoter (Ne-PAD4 −/− ), and ageing them for 2 years together with littermate controls (PAD4 fl/fl ). Ne-PAD4 −/− mice showed protection against age-induced fibrosis, seen by reduced cardiac collagen deposition. Echocardiography analysis of structural and functional parameters also demonstrated preservation of both systolic and diastolic function with MRP8-driven PAD4 deletion. Furthermore, cardiac gene expression and plasma cytokine levels were evaluated. Cardiac genes and plasma cytokines involved in neutrophil recruitment were downregulated in aged Ne-PAD4 −/− animals compared to PAD4 fl/fl controls, including decreased levels of C-X-C ligand 1 (CXCL1). Our data confirm PAD4 involvement from circulating neutrophils in detrimental cardiac remodelling, leading to cardiac dysfunction with old age. Deletion of PAD4 in MRP8-expressing cells impacts the CXCL1–CXCR2 axis, known to be involved in heart failure development. This supports the future use of PAD4 inhibitors in cardiovascular disease. This article is part of the Theo Murphy meeting issue ‘The virtues and vices of protein citrullination’.

11 November 2023 in Research and Practice in Thrombosis and Haemostasis
Verified
Journal Article
Open access
KBK. Bomhals
K. Bomhals
SKS. Kraisin
S. Kraisin
VSV. Spalart
V. Spalart
SMS. Meyers
S. Meyers
MSM. Stroobants
M. Stroobants
KMK. Martinod
K. Martinod